100 episodes

NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit back and listen to market updates, interviews and company press releases. NetworkNewsAudio keeps you informed on publicly traded companies we’re watching. The audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio is a Brand Awareness Distribution Solution from NetworkNewsWire.

The NetworkNewsAudio News Podcast networknewsaudionews

    • News

NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit back and listen to market updates, interviews and company press releases. NetworkNewsAudio keeps you informed on publicly traded companies we’re watching. The audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio is a Brand Awareness Distribution Solution from NetworkNewsWire.

    Knightscope, Inc. (NASDAQ: KSCP) Featured in Syndicated Broadcast Covering Largest Contract in Company History

    Knightscope, Inc. (NASDAQ: KSCP) Featured in Syndicated Broadcast Covering Largest Contract in Company History

    Knightscope, Inc. (NASDAQ: KSCP), a leading developer of autonomous security robots, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers Knightscope’s recent securement of the largest single contract in the company’s history alongside two new contracts from cities in New York and Georgia. 
    “Knightscope continues to deliver on its promise to rapidly grow the Company and help make the United States of America the safest country in the world,” William Santana Li, Chairman and CEO of Knightscope, stated in the news release from last week. “Today’s announcement further supports my recent public address where we project tripling our annualized revenue over the next twelve months.” 
    To hear the audio production, visit: https://www.nnw.fm/FjVcX  
    To read the original press release, visit: https://nnw.fm/A9OK4 

    • 4 min
    • video
    Knightscope, Inc. (NASDAQ: KSCP) Featured in Syndicated Broadcast Covering Largest Contract in Company History [Video Edition]

    Knightscope, Inc. (NASDAQ: KSCP) Featured in Syndicated Broadcast Covering Largest Contract in Company History [Video Edition]

    Knightscope, Inc. (NASDAQ: KSCP), a leading developer of autonomous security robots, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers Knightscope’s recent securement of the largest single contract in the company’s history alongside two new contracts from cities in New York and Georgia. 
    “Knightscope continues to deliver on its promise to rapidly grow the Company and help make the United States of America the safest country in the world,” William Santana Li, Chairman and CEO of Knightscope, stated in the news release from last week. “Today’s announcement further supports my recent public address where we project tripling our annualized revenue over the next twelve months.” 
    To hear the audio production, visit: https://www.nnw.fm/FjVcX  
    To read the original press release, visit: https://nnw.fm/A9OK4 

    • 4 min
    NetworkNewsAudio News-Knightscope, Inc. (NASDAQ: KSCP) Featured in Syndicated Broadcast Covering The Rise of Robots — Already Here, More Are Coming

    NetworkNewsAudio News-Knightscope, Inc. (NASDAQ: KSCP) Featured in Syndicated Broadcast Covering The Rise of Robots — Already Here, More Are Coming

    NetworkNewsWire Editorial Coverage: Although some people may be surprised, today’s world is full of robots. While these electro-mechanical devices may not be in the form of a cyborg RoboCop, they’re already serving people in countless ways. Industrial robots are a primary application today, with the world becoming accustomed to, and even expecting, life-altering technologies as robots shuttle people around, perform surgeries, keep communities safe, and much more. A global market summary by the International Federation of Robotics showed the robot trend accelerating, with a record 517,000 new industrial robots installed in factories around the world in 2021, up 31% from 2020. A host of innovative companies — including Knightscope, Inc. (NASDAQ: KSCP) (Profile), Velodyne Lidar Inc. (NASDAQ: VLDR), Pacific Gas & Electric Co. (NYSE: PCG), NVIDIA Corporation (NASDAQ: NVDA) and Palantir Technologies Inc. (NYSE: PLTR) — are investing in, developing and deploying leading-edge technology that is proving the value of robots in everyday lives or increasing their long-term potential.  
     
    Approximately 2.7 million industrial robots were in use in 2020, creating a global market valued at $55 billion that is expected to reach $165 billion by 2028. 
    Knightscope robots have 1.8-plus million hours of operation, have been documented to deter criminal activity and have proven invaluable in convictions of crimes. 
    Knightscope completed its first acquisition in October, buying CASE Emergency Systems. 
    November has seen a surge of new orders, activations for Knightscope crime-fighting robots and CASE emergency phones. 
     
    Click here to view the custom infographic of the Knightscope, Inc. editorial. 

    • 11 min
    • video
    NetworkNewsAudio News-Knightscope, Inc. (NASDAQ: KSCP) Featured in Syndicated Broadcast Covering The Rise of Robots — Already Here, More Are Coming [Video Edition]

    NetworkNewsAudio News-Knightscope, Inc. (NASDAQ: KSCP) Featured in Syndicated Broadcast Covering The Rise of Robots — Already Here, More Are Coming [Video Edition]

    NetworkNewsWire Editorial Coverage: Although some people may be surprised, today’s world is full of robots. While these electro-mechanical devices may not be in the form of a cyborg RoboCop, they’re already serving people in countless ways. Industrial robots are a primary application today, with the world becoming accustomed to, and even expecting, life-altering technologies as robots shuttle people around, perform surgeries, keep communities safe, and much more. A global market summary by the International Federation of Robotics showed the robot trend accelerating, with a record 517,000 new industrial robots installed in factories around the world in 2021, up 31% from 2020. A host of innovative companies — including Knightscope, Inc. (NASDAQ: KSCP) (Profile), Velodyne Lidar Inc. (NASDAQ: VLDR), Pacific Gas & Electric Co. (NYSE: PCG), NVIDIA Corporation (NASDAQ: NVDA) and Palantir Technologies Inc. (NYSE: PLTR) — are investing in, developing and deploying leading-edge technology that is proving the value of robots in everyday lives or increasing their long-term potential.  
     
    Approximately 2.7 million industrial robots were in use in 2020, creating a global market valued at $55 billion that is expected to reach $165 billion by 2028. 
    Knightscope robots have 1.8-plus million hours of operation, have been documented to deter criminal activity and have proven invaluable in convictions of crimes. 
    Knightscope completed its first acquisition in October, buying CASE Emergency Systems. 
    November has seen a surge of new orders, activations for Knightscope crime-fighting robots and CASE emergency phones. 
     
    Click here to view the custom infographic of the Knightscope, Inc. editorial. 

    • 11 min
    CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Featured in Syndicated Broadcast Covering Activation of First Clinical Trial Sites in Europe Evaluating Berubicin for the Treatment of GBM

    CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Featured in Syndicated Broadcast Covering Activation of First Clinical Trial Sites in Europe Evaluating Berubicin for the Treatment of GBM

    CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers CNS Pharmaceuticals’ recent announcement highlighting the activation of its first clinical trial sites in Europe for the ongoing potentially pivotal global trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (GBM), one of the most aggressive types of brain cancer.
    To hear the audio production, visit: https://www.nnw.fm/TCHxT
    To read the original press release, visit: https://nnw.fm/js5dD
    “Our primary focus continues to be on advancing the clinical development of Berubicin as a potential treatment option for this devastating disease. Over the course of this year, we have worked diligently to expand patient eligibility for our potentially pivotal trial and bolster our international presence now realized with the activation of the first two European clinical trial sites,” John Climaco, CEO of CNS Pharmaceuticals, stated in the news release. “This is a true testament to our team's commitment to and the execution of this important clinical program.”

    • 6 min
    • video
    CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Featured in Syndicated Broadcast Covering Activation of First Clinical Trial Sites in Europe Evaluating Berubicin for the Treatment of GBM [Video Edition]

    CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Featured in Syndicated Broadcast Covering Activation of First Clinical Trial Sites in Europe Evaluating Berubicin for the Treatment of GBM [Video Edition]

    CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers CNS Pharmaceuticals’ recent announcement highlighting the activation of its first clinical trial sites in Europe for the ongoing potentially pivotal global trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (GBM), one of the most aggressive types of brain cancer.
    To hear the audio production, visit: https://www.nnw.fm/TCHxT
    To read the original press release, visit: https://nnw.fm/js5dD
    “Our primary focus continues to be on advancing the clinical development of Berubicin as a potential treatment option for this devastating disease. Over the course of this year, we have worked diligently to expand patient eligibility for our potentially pivotal trial and bolster our international presence now realized with the activation of the first two European clinical trial sites,” John Climaco, CEO of CNS Pharmaceuticals, stated in the news release. “This is a true testament to our team's commitment to and the execution of this important clinical program.”

    • 6 min

Top Podcasts In News

The New York Times
NPR
The Daily Wire
Cumulus Podcast Network | Dan Bongino
Serial Productions & The New York Times
The Daily Wire